India's Pharmaceutical Exports

Country Profile

Serbia

Serbia is an emerging destination for Indian pharmaceutical exports — $15.1M in FY 2025–26, with 1.9× growth over the past decade. Medicine Ingredients accounts for 52% of shipments, with vaccines contributing $46K. The compound annual growth rate since FY2015 stands at 5.9%.

🇷🇸 $15.1M · 1.9× growth since FY2015 · 5.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$15.1M
Exports FY2025–26 DGCIS
1.9×
Growth FY2015→2026
5.9%
CAGR FY2015→2026
52%
Medicine Ingredients Share
5
Product Categories Supplied
Serbia is an emerging destination for Indian pharmaceutical exports — $15.1M in FY 2025–26, with 1.9× growth over the past decade. Medicine Ingredients accounts for 52% of shipments, with vaccines contributing $46K. The compound annual growth rate since FY2015 stands at 5.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $7.78M (51.6%) Medicines $6.58M (43.6%) Surgical & Hospital Supplies $512K (3.4%) Traditional & Herbal $160K (1.1%) Vaccines $46K (0.3%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Serbia in the RBI overseas direct investment dataset (2011–2026).